Fusion Pharmaceuticals Inc.·4

Jan 9, 6:45 AM ET

Rawat Mohit 4

4 · Fusion Pharmaceuticals Inc. · Filed Jan 9, 2023

Insider Transaction Report

Form 4
Period: 2023-01-05
Rawat Mohit
President and CBO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-05+300,000300,000 total
    Exercise: $3.75Exp: 2033-01-04Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]This option vests in 48 equal monthly installments beginning on February 5, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION